Kodiak Sciences KOD 深 沪
等待开盘 08-19 09:30:00 美东时间
11.25
+0.680
+6.43%
华盛通- 最 高11.29
- 今 开10.38
- 成交量 115.10万股
- 最 低 9.4534
- 昨 收 10.57
- 总市值 5.94亿
- 52周最高 11.5999
- 市盈率 静 --
- 换手率 2.18%
- 52周最低 1.92
- 委 比 -70.25%
- 总股本 5276.35万
- 历史最高 171.21
- 量 比 1.35
- 振 幅 17.38%
- 历史最低 1.37
- 每 手 1
- 风险率 2.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多JP Morgan Upgrades Kodiak Sciences to Neutral, Announces $15 Price Target
JP Morgan analyst Anupam Rama upgrades Kodiak Sciences (NASDAQ:KOD) from Underweight to Neutral and announces $15 price target.
08-14 18:45
Nuclear Energy Newcomers Electrify Final Day of EnerCom's 30th Anniversary Energy Investment Conference
Five Nuclear Companies to Present at EnerCom Denver – The Energy Investment Conference Qualified Investors, Analysts and Energy Industry Professionals Can Register at No Cost at www.enercom...
07-24 03:14
Market-Moving News for July 15th
TTD: 16% | The Trade Desk Will Replace Ansys In The S&P 500 Effective Prior To The Opening Of Trading On Friday, July 18 XAGE: 106% | Longevity Health Executes Definitive Merger Agreement With True
07-15 19:15
EnerCom Denver Releases Full Presenter Lineup for Landmark 30th Energy Investment Conference
Conference Lineup Features C-Suite Representation from over 75 Confirmed Companies Industry Panel Topics Include The Resurgence of Exploration, Private Companies, The Rise of Asset-Backed Se...
07-15 02:53
Kodiak Sciences shares are trading lower after the company reported worse-than-expected Q1 EPS results.
Kodiak Sciences shares are trading lower after the company reported worse-than-...
05-15 22:29
Kodiak Sciences Q1 EPS $(1.09) Misses $(0.87) Estimate
Kodiak Sciences (NASDAQ:KOD) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.87) by 25.29 percent. This is a 32.93 percent decrease over losses of $(0.82) per share from
05-15 04:30
快讯 | Kodiak Sciences 2023年第一季度净利润美元指数 -5746.1万
Kodiak Sciences Q1 Net Income USD -57.461 Million
05-15 04:15
快讯 | Kodiak Sciences 宣布近期业务亮点及2025年第一季度财务业绩
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Fin...
05-15 04:15
美股大行评级 | 潜在涨幅778.38%！HC Wainwright & Co.上调BioLine Rx目标价至26美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1113752959213998081.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BioLine Rx(BLRX)"买入"评级，目标价从9美元升至26美元</p> <p>• 德银：上调固特异轮胎橡胶(GT)评级至"买入"，目标价13美元</p> <p
04-01 09:48
